Cargando…
Combination therapy with lansoprazole and cholecalciferol is associated with a slower decline in residual beta-cell function and lower insulin requirements in children with recent onset type 1 diabetes: results of a pilot study
OBJECTIVE: To investigate the effects of combination therapy with cholecalciferol and lansoprazole on residual β-cell function and glycemic control in children with new-onset type 1 diabetes. METHODS: Children aged 6-12 years with type 1 diabetes were allocated to receive cholecalciferol and lansopr...
Autores principales: | Reddy, Raghunatha, Dayal, Devi, Sachdeva, Naresh, Attri, Savita Verma, Gupta, Vinod Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744432/ https://www.ncbi.nlm.nih.gov/pubmed/36449759 http://dx.doi.org/10.31744/einstein_journal/2022AO0149 |
Ejemplares similares
-
Daily Versus Alternate Day Thyroxine Therapy to Maintain Euthyroidism in Children With Congenital Hypothyroidism
por: Dayal, Devi, et al.
Publicado: (2013) -
Serial urinary neutrophil gelatinase associated lipocalin in pediatric diabetic ketoacidosis with acute kidney injury
por: Williams, Vijai, et al.
Publicado: (2021) -
The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production
por: Badiola, Nahuai, et al.
Publicado: (2013) -
Efficacy of soluble lansoprazole-impregnated beta-tricalcium phosphate for bone regeneration
por: Mishima, Kenichi, et al.
Publicado: (2022) -
Comparative efficacy of early morning versus bedtime administration of levothyroxine in children with hypothyroidism: a prospective, open label, randomized, case-control study
por: Navid, Azhar, et al.
Publicado: (2021)